276 related articles for article (PubMed ID: 37493896)
21. TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target.
Ojaimi YA; Dangoumau A; Alarcan H; Hergesheimer R; Vourc'h P; Corcia P; Lanznaster D; Blasco H
Expert Opin Ther Targets; 2022 Jun; 26(6):575-592. PubMed ID: 35652285
[TBL] [Abstract][Full Text] [Related]
22. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.
Mishima T; Koga S; Lin WL; Kasanuki K; Castanedes-Casey M; Wszolek ZK; Oh SJ; Tsuboi Y; Dickson DW
J Neuropathol Exp Neurol; 2017 Aug; 76(8):676-682. PubMed ID: 28789478
[TBL] [Abstract][Full Text] [Related]
23. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
Gao J; Wang L; Yan T; Perry G; Wang X
Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
[TBL] [Abstract][Full Text] [Related]
24. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
25. PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.
Joardar A; Menzl J; Podolsky TC; Manzo E; Estes PS; Ashford S; Zarnescu DC
Hum Mol Genet; 2015 Mar; 24(6):1741-54. PubMed ID: 25432537
[TBL] [Abstract][Full Text] [Related]
26. Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.
Matsukawa K; Hashimoto T; Matsumoto T; Ihara R; Chihara T; Miura M; Wakabayashi T; Iwatsubo T
J Biol Chem; 2016 Nov; 291(45):23464-23476. PubMed ID: 27634045
[TBL] [Abstract][Full Text] [Related]
27. Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly.
Jantrapirom S; Lo Piccolo L; Yoshida H; Yamaguchi M
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3038-3049. PubMed ID: 29936333
[TBL] [Abstract][Full Text] [Related]
28. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
29. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 Proteinopathy Specific Biomarker Development.
Cordts I; Wachinger A; Scialo C; Lingor P; Polymenidou M; Buratti E; Feneberg E
Cells; 2023 Feb; 12(4):. PubMed ID: 36831264
[TBL] [Abstract][Full Text] [Related]
31. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
[TBL] [Abstract][Full Text] [Related]
32. Restoration of Motor Defects Caused by Loss of
Lembke KM; Scudder C; Morton DB
J Neurosci; 2017 Sep; 37(39):9486-9497. PubMed ID: 28847811
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
34. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
35. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
36. Progranulin and TDP-43: mechanistic links and future directions.
Kumar-Singh S
J Mol Neurosci; 2011 Nov; 45(3):561-73. PubMed ID: 21863317
[TBL] [Abstract][Full Text] [Related]
37. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.
Scotter EL; Chen HJ; Shaw CE
Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699
[TBL] [Abstract][Full Text] [Related]
39. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
[TBL] [Abstract][Full Text] [Related]
40. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
